Monoclonal antibody is produced by immunizing animals with a recombinant protein specific to the amino terminus of Ki-67 protein.
单克隆抗体由合成肽段免疫动物产生，该肽段与Ki - 67蛋白的氨基端邻近残基序列一致。
Monoclonal antibody is produced by immunizing animals with recombinant protein specific to the amino terminus of human Ki-67 protein.
单克隆抗体由合成肽段免疫动物产生，该肽段与人Ki - 67蛋白的氨基端一致。
Monoclonal antibody is produced by immunizing animals with a recombinant protein specific to the amino terminus of human Ki-67 protein.
单克隆抗体由合成肽段免疫动物产生，该肽段与人Ki - 67蛋白的氨基端邻近残基序列一致。
Monoclonal antibody is produced by immunizing animals with a recombinant protein specific to the amino terminus of human Ki-67 protein.
单克隆抗体由合成肽段免疫动物产生，该肽段与人Ki-67蛋白的氨基端一致。
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the amino terminus of human Ki-67 protein.
单克隆抗体由合成肽段免疫动物产生，该肽段与人Ki - 67蛋白的氨基端一致。
Research studies have explored the use of Ki-67, along with other markers, as potential prognostic or predictive markers in breast cancer and other malignant diseases (4).
研究已经将Ki - 67与其他的标记，作为乳腺癌和其他恶性疾病中的潜在的预后和预测标记(4)。
This results showed that mutant P53 expression was associated with a high Ki-67 LI and high histologic grade of tumors. P53 overexpression might be a genetic marker of tumor malignancy.
结果表明，突变型P53蛋白的表达与脑肿瘤的组织类型，分化程度及细胞的增殖有关，而它的高表达又可能是肿瘤恶性表型或转移的标志之一。
This results showed that mutant P53 expression was associated with a high Ki-67 LI and high histologic grade of tumors. P53 overexpression might be a genetic marker of tumor malignancy.
结果表明，突变型P53蛋白的表达与脑肿瘤的组织类型，分化程度及细胞的增殖有关，而它的高表达又可能是肿瘤恶性表型或转移的标志之一。
应用推荐